Clinical Trials Browser

Terminated × pidilizumab × Lymphoid × Clear all

NCT02530125 2018-03-19

Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission

Phase 2 Terminated

4 enrolled 8 charts

Lymphoma, Large B-Cell, Diffuse